Meeder Asset Management’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-50
| Closed | -$3K | – | 2410 |
|
|
2021
Q4 | $3K | Hold |
50
| – | – | ﹤0.01% | 937 |
|
|
2021
Q3 | $4K | Hold |
50
| – | – | ﹤0.01% | 2001 |
|
|
2021
Q2 | $6K | Hold |
50
| – | – | ﹤0.01% | 1874 |
|
|
2021
Q1 | $6K | Sell |
50
-140
| -74% | -$16.8K | ﹤0.01% | 1791 |
|
|
2020
Q4 | $20K | Sell |
190
-219
| -54% | -$23.1K | ﹤0.01% | 788 |
|
|
2020
Q3 | $57K | Sell |
409
-11
| -3% | -$1.53K | ﹤0.01% | 928 |
|
|
2020
Q2 | $137K | Buy |
420
+354
| +536% | +$115K | 0.01% | 692 |
|
|
2020
Q1 | $5K | Buy |
+66
| New | +$5K | ﹤0.01% | 1783 |
|
|
2019
Q2 | – | Sell |
-411
| Closed | -$18K | – | 2083 |
|
|
2019
Q1 | $18K | Sell |
411
-816
| -67% | -$35.7K | ﹤0.01% | 1103 |
|
|
2018
Q4 | $59K | Buy |
1,227
+1,030
| +523% | +$49.5K | 0.01% | 770 |
|
|
2018
Q3 | $13K | Buy |
197
+158
| +405% | +$10.4K | ﹤0.01% | 1115 |
|
|
2018
Q2 | $1.84K | Buy |
39
+25
| +179% | +$1.18K | ﹤0.01% | 1427 |
|
|
2018
Q1 | $1K | Sell |
14
-31
| -69% | -$2.21K | ﹤0.01% | 1454 |
|
|
2017
Q4 | $2K | Sell |
45
-13
| -22% | -$578 | ﹤0.01% | 1491 |
|
|
2017
Q3 | $4K | Sell |
58
-49
| -46% | -$3.38K | ﹤0.01% | 1321 |
|
|
2017
Q2 | $10K | Hold |
107
| – | – | ﹤0.01% | 990 |
|
|
2017
Q1 | $9K | Buy |
107
+41
| +62% | +$3.45K | ﹤0.01% | 875 |
|
|
2016
Q4 | $5K | Buy |
+66
| New | +$5K | ﹤0.01% | 856 |
|